1. DSpace at My University
  2. FACULTY OF TECHNOLOGY & ENGINEERING
  3. DEPARTMENT OF PHARMACY
  4. THESES-Pharmacy
Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2516
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBhavsar, Dhaval B.-
dc.date.accessioned2022-11-14T22:41:43Z-
dc.date.available2022-11-14T22:41:43Z-
dc.date.issued2019-03-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2516-
dc.publisherThe Maharaja Sayajirao University of Barodaen_US
dc.subjectAnticancer agenten_US
dc.subjectSilica nanoparticlesen_US
dc.subjectPharmacyen_US
dc.titleDevelopment of mesoporous silica nanoparticles as a novel platform for targeted delivery and controlled release of anticancer agenten_US
dc.typeThesisen_US
Appears in Collections:THESES-Pharmacy

Files in This Item:
File Description SizeFormat 
1. Title page.pdf113.94 kBAdobe PDFView/Open
2. Certificate.pdf96.22 kBAdobe PDFView/Open
3. Declaration.pdf52.66 kBAdobe PDFView/Open
4. Acknowledgement.pdf597.11 kBAdobe PDFView/Open
5. Index.pdf.pdf69.34 kBAdobe PDFView/Open
6. List of tables.pdf71.84 kBAdobe PDFView/Open
7. List of figures.pdf87.67 kBAdobe PDFView/Open
8. Chapter 1. Introduction.pdf387.88 kBAdobe PDFView/Open
9. Chapter 2. Literature survey.pdf1.2 MBAdobe PDFView/Open
10. Chapter 3. Analytical methods.pdf656.18 kBAdobe PDFView/Open
11. Chapter 4. Synthesis and Characterisation of mesoporous silica nanoparticles.pdf963.64 kBAdobe PDFView/Open
12. Chapter 5. Toxicity and biocompatibility thesis.pdf1.04 MBAdobe PDFView/Open
13. Chapter 6. Surface functionalizations, drug loading and evaluations.pdf1.12 MBAdobe PDFView/Open
14. Chapter 7. Cell line studies.pdf940.51 kBAdobe PDFView/Open
15. Chapter 8. In vivo anticancer studies.pdf1.28 MBAdobe PDFView/Open
16. Chapter 9. Summary and conclusions.pdf297.17 kBAdobe PDFView/Open
17. List of publications.pdf36.66 kBAdobe PDFView/Open
18. Synopsis.pdf214.44 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.